Xencor, Inc. (XNCR)
24.63
+0.13
(+0.53%)
USD |
NASDAQ |
Oct 09, 16:00
24.59
-0.04
(-0.16%)
Pre-Market: 20:00
Xencor Net Income (Quarterly) : -21.73M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -21.73M |
| March 31, 2026 | -128.92M |
| December 31, 2025 | -6.653M |
| September 30, 2025 | -6.027M |
| June 30, 2025 | -30.82M |
| March 31, 2025 | -48.63M |
| December 31, 2024 | -46.20M |
| September 30, 2024 | -46.30M |
| June 30, 2024 | -67.41M |
| March 31, 2024 | -68.71M |
| December 31, 2023 | -19.26M |
| September 30, 2023 | -24.27M |
| June 30, 2023 | -21.95M |
| March 31, 2023 | -60.76M |
| December 31, 2022 | -12.04M |
| September 30, 2022 | -32.76M |
| June 30, 2022 | -33.98M |
| March 31, 2022 | 23.59M |
| December 31, 2021 | 73.06M |
| September 30, 2021 | -40.19M |
| June 30, 2021 | 52.25M |
| March 31, 2021 | -2.487M |
| December 31, 2020 | -13.69M |
| September 30, 2020 | -12.55M |
| June 30, 2020 | -35.02M |
| Date | Value |
|---|---|
| March 31, 2020 | -8.074M |
| December 31, 2019 | -26.91M |
| September 30, 2019 | -10.22M |
| June 30, 2019 | -16.03M |
| March 31, 2019 | 80.04M |
| December 31, 2018 | -18.20M |
| September 30, 2018 | 3.15M |
| June 30, 2018 | -25.87M |
| March 31, 2018 | -29.49M |
| December 31, 2017 | 7.366M |
| September 30, 2017 | -22.65M |
| June 30, 2017 | -7.725M |
| March 31, 2017 | -15.48M |
| December 31, 2016 | -9.065M |
| September 30, 2016 | -8.077M |
| June 30, 2016 | 47.16M |
| March 31, 2016 | -6.398M |
| December 31, 2015 | 7.757M |
| September 30, 2015 | -10.04M |
| June 30, 2015 | -8.868M |
| March 31, 2015 | -6.444M |
| December 31, 2014 | -1.35M |
| September 30, 2014 | -6.278M |
| June 30, 2014 | -5.044M |
| March 31, 2014 | -3.751M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 51.29M |
| UroGen Pharma Ltd. | -14.35M |
| MeiraGTx Holdings Plc | 160.67M |
| IDEAYA Biosciences, Inc. | -112.45M |
| Iovance Biotherapeutics, Inc. | -47.32M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 51.22M |
| Total Expenses (Quarterly) | 72.95M |
| EPS Diluted (Quarterly) | -0.2864 |
| Enterprise Value | 1.544B |
| Gross Profit Margin (Quarterly) | 95.24% |
| Profit Margin (Quarterly) | -42.42% |
| Earnings Yield | -8.81% |
| Normalized Earnings Yield | -10.69 |